Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: Lessons from the REDUCE study

Michael Marberger, Stephen J. Freedland, Gerald L. Andriole, Mark Emberton, Curtis Pettaway, Francesco Montorsi, Claudio Teloken, Roger S. Rittmaster, Matthew C. Somerville, Ramiro Castro

Research output: Contribution to journalArticlepeer-review

39 Scopus citations

Fingerprint

Dive into the research topics of 'Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: Lessons from the REDUCE study'. Together they form a unique fingerprint.

Medicine & Life Sciences